Vasoconstriction in active skeletal muscles: a potential role for P2X purinergic receptors? J Appl Physiol 95: 953-959, 2003. First published May 23, 2003 10.1152/ japplphysiol.00173.2003.-There is evidence that ATP acts as a neurotransmitter in vascular smooth muscle and is coreleased with norepinephrine from sympathetic nerves. We hypothesized that P2X-receptor stimulation with the selective P2X-receptor agonist ␣,-methylene ATP would produce vasoconstriction in resting and exercising skeletal muscle. Six mongrel dogs were instrumented chronically with flow probes on the external iliac arteries of both hindlimbs and a catheter in one femoral artery. The selective P2X agonist ␣,-methylene ATP was infused as a bolus into the femoral artery catheter at rest and during mild, moderate, and heavy exercise. Intra-arterial infusions of ␣,-methylene ATP elicited reductions in vascular conductance of 54 Ϯ 5, 49 Ϯ 8, 39 Ϯ 8, and 30 Ϯ 6% at rest, 3 miles/h, 6 miles/h, and 6 miles/h at a 10% grade, respectively. The agonist infusions did not affect blood flow in the contralateral iliac artery. To examine whether nitric oxide is responsible for the attenuated vasoconstrictor response to P2X stimulation, the infusions were repeated in the presence of N G -nitro-L-arginine methyl ester. After nitric oxide synthase blockade, intraarterial infusions of ␣,-methylene ATP elicited reductions in vascular conductance of 56 Ϯ 7, 61 Ϯ 8, 52 Ϯ 9, and 40 Ϯ 7% at rest, 3 miles/h, 6 miles/h, and 6 miles/h at a 10% grade, respectively. P2X-receptor responsiveness was attenuated during exercise compared with rest. Blockade of nitric oxide production did not affect the attenuation of P2X-receptor responsiveness during exercise. These data support the hypothesis that P2X purinergic receptors can produce vasoconstriction in exercising skeletal muscle. blood flow; sympatholysis; autonomic nervous system; dogs FOR YEARS, SYMPATHETIC VASOCONSTRICTION has been thought to be mediated entirely by norepinephrine released from sympathetic nerve terminals. However, there is strong evidence that ATP acts as a neurotransmitter in vascular smooth muscle and is coreleased with norepinephrine from sympathetic nerves (9,18,21,29). The release of ATP is thought to stimulate a purinergic receptor (P2). P2X purinergic receptors, which mediate vasoconstriction, are found predominantly in vascular smooth muscle, whereas P2Y purinergic receptors, which mediate vasodilation, are primarily located on endothelial cells (11). P2X receptors on vascular smooth muscle cells are preferentially stimulated by ATP from sympathetic nerve endings (17). Although two recent studies (1,19) showed that P2X-receptor stimulation produces vasoconstriction in the hindlimb of anesthetized cats and rats, it is unknown whether stimulation of P2X receptors in the arterial vasculature of skeletal muscle will produce vasoconstriction during exercise.In the past, the ability of the sympathetic nervous system to restrain blood flow in active skeletal muscle has been questioned (14,24,26)...